|

Comparator 1: Dapagliflozin/Rosuvastatin placebo Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • CMG Pharmaceutical Co. Ltd1

Indications

  • Dyslipidemia1
  • Diabetes1
  • Type 2 Diabetes1

Other1 trial

Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.